Clinical Trials Logo

Filter by:
NCT ID: NCT01741038 Withdrawn - Clinical trials for Metastatic Colorectal Cancer

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Start date: December 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This is a personalized anti-cancer vaccine protocol which includes an in-situ (in the body) cancer vaccine step which combines killing a single metastatic tumor lesion by use of cryoablation in order to cause the release of tumor-specific markers to the immune system and then injecting bioengineered allogeneic immune cells (AlloStim) into the lesion as an adjuvant in order to modulate the immune response and educate the immune system to kill other tumor cells where ever they reside in the body.

NCT ID: NCT01737827 Terminated - Clinical trials for Advanced Hepatocellular Carcinoma With c-MET Dysregulation

Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.

Start date: March 25, 2013
Phase: Phase 2
Study type: Interventional

This study is to find out if INC280 is safe and has beneficial effects in patients with advanced hepatocellular carcinoma known to have dysregulation of c-MET pathway.

NCT ID: NCT01736774 Completed - Headache Clinical Trials

Exercise and Manipulative Therapy for Older Persons With Headache

Start date: December 2012
Phase: N/A
Study type: Interventional

The presence of cervical musculoskeletal impairment is not specific to cervicogenic headache but other various frequent intermittent headache types (i.e. migraine and tension-type headache) in the elderly population. There has been no trial to date which has investigated the effectiveness of physiotherapy treatment specifically for older persons with various types of headache with associated neck pain and cervical musculoskeletal impairment. Thus, the purpose of study investigate the efficacy of physiotherapy treatment for older persons who have headache concomitant with neck pain and musculoskeletal impairment

NCT ID: NCT01736215 Terminated - Clinical trials for Anemia - Cancer Related

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Start date: November 2010
Phase: Phase 4
Study type: Observational

The purpose of this observational study is to evaluate the predictors of response to erythropoietin (hormone secreted by kidney that helps in formation of red blood cells in bone marrow) treatment in participants with cancer (abnormal tissue that grows and spreads in the body until it kills) related anemia (decreased number of red blood cells), receiving chemotherapy (treatment of cancer using drugs).

NCT ID: NCT01732822 Completed - Clinical trials for Peripheral Artery Disease

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

EUCLID
Start date: December 4, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

NCT ID: NCT01730534 Completed - Clinical trials for Diabetes Mellitus, Non-Insulin-Dependent

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

DECLARE-TIMI58
Start date: April 25, 2013
Phase: Phase 3
Study type: Interventional

This study is being carried out to determine the effect of dapagliflozin on cardiovacular outcomes when added to current background therapy in patients with type 2 diabetes with either established cardiovacular disease or cardiovascular risk factors.

NCT ID: NCT01726790 Recruiting - Clinical trials for Corneal Endothelial Cell Loss

Effect of Intravitreal Bevacizumab on Corneal Endothelium

Start date: August 2011
Phase: N/A
Study type: Observational

To evaluate corneal endothelium cell change after intravitreal Bevacizumab injection

NCT ID: NCT01726530 Completed - Clinical trials for Postoperative Pain Relief

Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial

Start date: June 2011
Phase: N/A
Study type: Interventional

Abdominal surgery causes severe postoperative pain. Multi-modal pain therapy is usually applied but there is no perfect choice. It depends on physician's skill and situation. The best regimen is patient-controlled analgesia, but it requires an expensive equipment. Transdermal fentanyl patch, usually used in chronic pain relief, can steadily release fentanyl into blood stream for 72 hours, but it has slow onset of 12 hours. Hypothesis: If Transdermal fentanyl patch is applied 10-12 hours before surgery, it may provide good analgesia for 72 hours.

NCT ID: NCT01725464 Completed - Hypoxia Clinical Trials

The Effect of Nasal Cannula During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy

Start date: November 2012
Phase: Phase 4
Study type: Interventional

During early postoperative after lung resection surgery, patients without oxygen supplementation may experience hypoxemia. Oxygen supplementation can be given via oxygen mask or cannular. In this study the investigators want to the sudy the effect of oxygen supplementation via oxygen cannular during the first 120 minutes after surgery

NCT ID: NCT01724892 Completed - Clinical trials for Epithelial Defect After Phototherapeutic Keratectomy

Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing

Start date: November 2012
Phase: Phase 4
Study type: Interventional

Corticosteroid has been used for the treatment after phototherapeutic keratectomy (PRK). Dexamethasone, a potent steroid can retard the corneal epithelial healing rate and has numerous serious complications, especially glaucoma. Loteprednol, a new generation of corticosteroid has less potency than dexamethasone and was proposed to has less side effect regarding intraocular pressure (IOP) elevation. Therefore, Investigators would like to compare the effect of dexamethasone and loteprednol on corneal epithelial healing rate after PRK and risk of glaucoma.